Optimal treatment of steroid sensitive nephrotic syndrome in children.

Optimal treatment in children with the initial episode.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27512

Enrollment

150

Registered

2005-09-07

Start date

2005-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Prednisolone therapy.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children from 9 months up to 16 years will be included; 2. Only children with idiopathic nephrotic syndrome will be included.

Exclusion criteria

Exclusion criteria: 1. Children with nephrotic syndrome due to a specific disease; 2. Children with more than five relapses; 3. Chilren younger than 9 month or older than 16 years.

Design outcomes

Primary

Measure	Time frame
Number of patients with frequent relapses.	—

Secondary

Measure	Time frame
Number of patients with sustained remission. Adverse effects of prednisolone. Cumulative dose op prednisolone during follow up.	—

Contacts

Public ContactN. Teeninga

Postbus 2040

n.teeninga@erasmusmc.nl+31 (0)10 7036588

Outcome results